share_log

Virpax Pharmaceuticals Q2 EPS $(0.50) Down From $(0.47) YoY

Virpax Pharmaceuticals Q2 EPS $(0.50) Down From $(0.47) YoY

Virpax制药公司第二季度每股收益为0.50美元,低于去年同期的0.47美元
Benzinga Real-time News ·  2022/08/15 09:06

Virpax Pharmaceuticals (NASDAQ:VRPX) reported quarterly losses of $(0.50) per share. This is a 6.38 percent decrease over losses of $(0.47) per share from the same period last year.

纳斯达克(VRPX:VRPX)公布季度每股亏损0.5美元。这比去年同期每股亏损0.47美元减少了6.38%。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发